Clinical Development of BRAF plus MEK Inhibitor Combinations
2020 · Trends in cancer · 327 citations
https://doi.org/10.1016/j.trecan.2020.05.009
C
Christina S. Baik
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
207
Papers
9.1K
Citations
37
h-index
77
i10-index
Christina S. Baik is an academic researcher from University of Washington. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Research Studies & Colorectal Cancer Treatments and Studies. The author has an h-index of 37, co-authored 176 publications.
Papers by this author
worksTrastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non–Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers
2018 · Clinical Cancer Research · 228 citations
https://doi.org/10.1158/1078-0432.ccr-18-1590
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
2024 · The Lancet Oncology · 134 citations
https://doi.org/10.1016/s1470-2045(24)00064-0
Endogenous CD4+ T Cells Recognize Neoantigens in Lung Cancer Patients, Including Recurrent Oncogenic <i>KRAS</i> and <i>ERBB2</i> ( <i>Her2</i> ) Driver Mutations
2019 · Cancer Immunology Research · 86 citations
https://doi.org/10.1158/2326-6066.cir-18-0402
A Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor–Naïve <i>EGFR</i> -Mutant Metastatic Non–Small Cell Lung Cancer (RAMOSE trial)
2024 · Journal of Clinical Oncology · 35 citations
https://doi.org/10.1200/jco.24.00533
Savolitinib plus osimertinib in epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer with MET overexpression and/or amplification following disease progression on osimertinib: primary results from the phase II SAVANNAH study
2025 · Annals of Oncology · 26 citations
https://doi.org/10.1016/j.annonc.2025.04.003
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat